US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jul 30, 2021 (5 years ago)

Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Stability Specifications; out of specification for shear.

What was recalled

Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice Weekly Rx Only a) 2 Systems NDC 68968-0525-2; b) 8 Systems NDC 68968-0525-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186

Recalling firm
Noven Pharmaceuticals Inc
NDC code
68968-0525-2
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0725-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Estradiol recalls

See all